ARS Pharmaceuticals, Inc. Common Stock (SPRY) News
Latest headlines that mention SPRY, newest first · each headline opens the original publisher
- Last price
- $3.92
- Day change
- -2.73%
- Next earnings
- 2026-11-09
SPRY headlines
latest coverageNeffy market share doubled as prescriber count tripled year over year.
ARS Pharmaceuticals stock collapsed Thursday after CVS Caremark declined to add its epinephrine spray, Neffy, to its formulary. The post ARS Pharma Collapses After CVS Punts Its Epinephrine Spray Decision To January appeared first on Investor's Business Daily .
Image source: The Motley Fool. Friday, May 15, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
Image source: The Motley Fool. Monday, March 9, 2026, at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
SPRY news alerts
Get an alert by email or push when a new headline mentions SPRY.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.